Has Dimitri Krainc, MD received payments from drug or device companies?

Yes. Drug and device makers reported $15,644 in general payments to Dimitri Krainc, MD across 8 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Dimitri Krainc, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Dimitri Krainc, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Dimitri Krainc, MD

Neurology · Chicago, ILNPI 1588654032

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $14,022 of the $15,644 with a category attached, or 89.6%. Eli Lilly accounts for 61.5% of it on its own, with 3 other manufacturers making up the rest. Reporting peaked in 2021 at $9,620 and has fallen 53.0% since, to $4,525 in 2025.

$15,644in general payments, 2019–2025

Across 8 payments — averaging $1955.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Eli Lilly$10K
F. Hoffmann-la Roche AG$3K
Sumitomo Pharma Co., Ltd.$2K
Genentech, Inc.$1K

$542,362in research payments, 2019–2025

Across 3 payments — averaging $180,787 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

AbbVie$542K

What the payments were for

Consulting fees$14,02290%
Speaking & faculty fees$1,0006%
Travel & lodging$5804%
Food & beverage$420%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Eli Lilly	2	$9,620
F. Hoffmann-la Roche AG	2	$3,305
Sumitomo Pharma Co., Ltd.	2	$1,500
Genentech, Inc.	2	$1,220

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

TRF$1,500

How this compares

$15,644 in reported general payments places this provider in the 85th percentile of 790 neurology providers in Illinois.

See all neurology providers in Illinois →

Medicare billing

Part B allowed, 2024

$2,457

Medicare patients

Services billed

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other neurology in Chicago

Augusto MiravalleChicago$1.4M
Adil JavedChicago$584K
Danny BegaChicago$442K
Michael SmithChicago$382K
Dusan StefoskiChicago$294K
Veronica CiprianiChicago$289K
Thomas ShoemakerChicago$278K
Bruce CohenChicago$276K
Margaret ParkChicago$245K
Leonard Verhagen MetmanChicago$245K

See the full list for Illinois →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →